LCZ696 (Sacubitril + Valsartan)

Sharaxaad Gaaban:

Magaca API Tilmaam Tilmaamid US DMF Midowga Yurub DMF CEP
LCZ696 (Sacubitril + Valsartan) Wadnaha oo istaaga Guriga dhexdiisa    


Faahfaahinta Alaabta

Tags Product

FAAHFAAHINTA Alaabada

Sharaxaada

LCZ696 (Sacubitril/Valsartan), oo ka kooban Valsartan (an ARB) iyo Sacubitril (AHU377) ee 1: 1 saamiga molar, waa fasalka koowaad, afka laga heli karo, iyo dual-acting angiotensin receptor-neprilysin (ARN) inhibitor ee hypertension. iyo wadne xanuun[1][2][3].LCZ696 waxay hagaajisaa wadnaha wadnaha ee sonkorowga iyadoo la xakameynayo bararka, cadaadiska oksaydhka iyo apoptosis.

 

Asalkii hore

LCZ696 waa kan ugu horreeya ee fasalka ARNi (angiotensin receptor neprilysin inhibitor) oo ka kooban unugyada anionic ee AR valsartan iyo neprilysin inhibitor prodrug AHU377 (1: 1 ratio) ee wadne xanuunka iyo hypertension.

Receptors-yaasha angiotensin waa G-protein-ku-xidhay-qabayaal.Waxay dhexdhexaadiyaan wadnaha iyo xididdada dhiigga iyo saamaynta kale ee angiotensin II kaas oo ah peptide bioactive ee nidaamka renin-angiotensin.Neprilysin waa endopeptidase dhexdhexaad ah oo hoos u dhigaya peptides-ka vasoactive-ka ah sida peptides natriuretic.Joojinta neprilysinku waxay kordhisaa diiradda peptides natriuretic taas oo gacan ka geysatay ilaalinta wadnaha, xididada iyo kelyaha.[1]

Jiirka Sprague-Dawley, maamulka afka ee LCZ696 wuxuu horseeday kor u kaca qiyaasta ku-tiirsanaanta difaaca ee peptide atrial natriuretic oo ka dhashay xannibaadda neprilysin.Jiirka labajibbaaran ee hypertensive transgenic, LCZ696 waxay keentay qiyaas ku-tiirsanaan iyo hoos u dhac joogto ah oo cadaadiska halbowlaha ah.Ka-qaybgalayaasha caafimaadka qaba, kala-sooc, laba-indho la'aan, daraasad la xakameeyey placebo ayaa xaqiijisay in LCZ696 ay bixisay xannibaadda neprilysin-ka iyo xannibaadda soo-dhoweynta AT1.LCZ696 waxay ahayd badbaado oo si wanaagsan loogu dul-qaatay aadanaha.[2] [3]

Tixraacyo:
McMurray JJ, Packer M, Desai AS iyo al.Joojinta Angiotensin-neprilysin iyo enalapril ee wadnaha oo aan shaqayn.N Engl J Med.2014 Seb 11;371(11):993-1004.
Gu J, Noe A, Chandra P, Al-Fayoumi S iyo al.Pharmacokinetics iyo farmacodynamics ee LCZ696, oo ah laba-jibbaar angiotensin receptor-neprilysin inhibitor (ARNi).J Clin Pharmacol.2010 Abriil; 50 (4): 401-14.
Langenickel TH, Dole WP.Angiotensin receptor-neprilysin inhibition oo leh LCZ696: hab cusub oo loogu talagalay daawaynta wadnaha oo aan shaqeynin, Drug Discov Today: Ther Strategies (2014)

 

Kaydinta

Budada

-20°C

3 sano
 

4°C

2 sano
Ku milmay

-80°C

6 bilood
 

-20°C

1 bil

Qaab dhismeedka kiimikada

LCZ696(Sacubitril + Valsartan)

SHAHAADADA

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

MAAREYN TAYO LEH

Quality management1

Soo jeedin18Mashaariicda Qiimaynta Joogtada Tayada ee la ansixiyay4iyo6mashaariicda ayaa ku socda ansixinta.

Quality management2

Nidaamka maaraynta tayada sare ee caalamiga ah ayaa dhigay aasaas adag oo iib ah.

Quality management3

Kormeerka tayada wuxuu ku socdaa dhammaan wareegga nolosha ee alaabta si loo hubiyo tayada iyo saameynta daaweynta.

Quality management4

Kooxda Arrimaha Sharciyaynta Xirfadlayaasha waxay taageertaa shuruudaha tayada inta lagu jiro codsiga iyo diiwaangelinta.

MAAMULKA SOO SAARKA

cpf5
cpf6

Khadka Baakadaha ee Countec ee Kuuriya

cpf7
cpf8

Khadka baakadaha dhalada ee Taiwan CVC

cpf9
cpf10

Taliyaaniga CAM Khadka Baakadaha

cpf11

Jarmal Fette Machine Compacting

cpf12

Japan Viswill Tablet Detector

cpf14-1

Qolka Xakamaynta DCS

SHAQAALAHA

iskaashiga caalamiga ah
International cooperation
iskaashiga gudaha
Domestic cooperation

  • Hore:
  • Xiga:

  • Halkan ku qor fariintaada oo noo soo dir